Purpose/Objectives: To assess the feasibility of auricular point acupressure to manage aromatase inhibitor-induced arthralgia.
Findings: After the four-week intervention, participants reported decreases in worst pain and pain interference, and improvements in physical function, cancer-related symptom severity, and interference. The proinflammatory cytokines and chemokines displayed a trend of a mean percentage reduction. The anti-inflammatory cytokine interleukin-13 increased from pre-to postintervention.
Conclusions: Auricular point acupressure is feasible and may be effective in managing arthralgia in breast cancer survivors. Implications for Nursing: Nurses can administer acupressure in clinical settings, which could enhance the management of aromatase inhibitor-induced arthralgia and contribute to a shift from traditional disease-based biomedical models to a broader, integrative, medical paradigm for managing aromatase inhibitor-induced arthralgia. A romatase inhibitor (AI) therapy has become an important standard of care for postmenopausal breast cancer survivors (PBCS) (Early Breast Cancer Trialists' Collaborative Group, 2015) . Adherence to this adjuvant endocrine therapy is an essential part of the multimodality treatment regimen of hormone-responsive breast cancer (Burstein et al., 2014; Hershman et al., 2010 Hershman et al., , 2011 ; however, adherence is challenging for patients because AI therapy requires daily use of an oral medication that must be continued for five years or longer (Hershman et al., 2010 (Hershman et al., , 2011 Murphy, Bartholomew, Carpentier, Bluethmann, & Vernon, 2012) . AI-induced arthralgia (AIA), particularly its high pain intensity, is a major challenge for optimal adherence to AI therapy (Hershman et al., 2010 (Hershman et al., , 2011 Hershman, Loprinzi, & Schneider, 2015) and contributes to a 20%-50% rate of premature discontinuation (Henry et al., 2008 (Henry et al., , 2012 Howell et al., 2005; Mao et al., 2009; Presant et al., 2007) . No effective
